Avanos Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Avanos Medical
AVNS Stock  USD 13.99  0.01  0.07%   
Avanos Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Avanos Medical's valuation are provided below:
Gross Profit
353.9 M
Profit Margin
(0.10)
Market Capitalization
649.4 M
Enterprise Value Revenue
1.0175
Revenue
701.2 M
There are over one hundred nineteen available fundamental signals for Avanos Medical, which can be analyzed over time and compared to other ratios. All traders should validate Avanos Medical's prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 2.3 B in 2026, whereas Market Cap is likely to drop slightly above 1.4 B in 2026.

Avanos Medical Total Revenue

800.07 Million

Check Avanos Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avanos Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 38.4 M, Interest Expense of 3.8 M or Selling General Administrative of 281.9 M, as well as many indicators such as Price To Sales Ratio of 0.71, Dividend Yield of 0.26 or PTB Ratio of 0.64. Avanos financial statements analysis is a perfect complement when working with Avanos Medical Valuation or Volatility modules.
  
Build AI portfolio with Avanos Stock
Check out the analysis of Avanos Medical Correlation against competitors.
For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Avanos Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding51.6 M46.4 M47.2 M
Slightly volatile
Short and Long Term Debt Total243.2 M129.1 M273.6 M
Very volatile
Property Plant And Equipment Net170.7 M141 M224.1 M
Slightly volatile
Non Current Assets Total1 B718.3 M1.4 B
Slightly volatile
Non Currrent Assets Other33.1 M31.5 M13.3 M
Slightly volatile
Cash And Short Term Investments152.2 M89.8 M128.5 M
Pretty Stable
Liabilities And Stockholders Equity1.5 B1.1 B1.9 B
Slightly volatile
Non Current Liabilities Total123.8 M130.3 M292.7 M
Pretty Stable
Property Plant And Equipment Gross197.1 M293.1 M252.8 M
Slightly volatile
Long Term Debt Total273 M203.7 M385.3 M
Slightly volatile
Capital Surpluse1.7 B1.9 B1.6 B
Slightly volatile
Non Current Liabilities Other9 M9.5 M28.2 M
Pretty Stable
Deferred Long Term Asset Charges11.9 M13.4 M14.6 M
Slightly volatile
Net Invested Capital1.1 B878.7 M1.5 B
Slightly volatile
Net Working Capital276.5 M190.2 M516.7 M
Slightly volatile
Capital Stock400 K450 K491.2 K
Slightly volatile
Capital Lease Obligations40.7 M28.6 M64.3 M
Slightly volatile

Avanos Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization38.4 M29 M47.7 M
Slightly volatile
Interest Expense3.8 M4 M12.4 M
Very volatile
Selling General Administrative281.9 M315.6 M348.2 M
Slightly volatile
Total Revenue800.1 M701.2 M1 B
Slightly volatile
Gross Profit354.5 M349 M446.6 M
Slightly volatile
Other Operating Expenses730.2 M762.8 M933.7 M
Slightly volatile
Research Development26.6 M23.1 M32.7 M
Slightly volatile
Cost Of Revenue445.5 M352.2 M580.5 M
Slightly volatile
Total Operating Expenses284.6 M410.6 M353.2 M
Slightly volatile
Non Operating Income Net Other2.1 M1.1 M2.4 M
Pretty Stable
Interest Income4.7 M3.2 M13.7 M
Slightly volatile
Non Recurring379.2 M426.6 M465.6 M
Slightly volatile
Reconciled Depreciation34.6 M38.9 M49.4 M
Slightly volatile
Selling And Marketing Expenses265.6 M298.8 M326.1 M
Slightly volatile

Avanos Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation12.3 M12.6 M10.7 M
Slightly volatile
Begin Period Cash Flow139.4 M107.7 M122.1 M
Slightly volatile
Depreciation41.8 M38.9 M51.5 M
Slightly volatile
Capital Expenditures30.8 M31.6 M38.2 M
Slightly volatile
End Period Cash Flow143.5 M89.8 M124.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.710.74311.7736
Very volatile
Dividend Yield0.260.290.3159
Slightly volatile
PTB Ratio0.640.66961.1707
Pretty Stable
Days Sales Outstanding59.554.031769.4393
Slightly volatile
Book Value Per Share30.5616.771629.8784
Slightly volatile
Stock Based Compensation To Revenue0.01150.01810.0137
Slightly volatile
Capex To Depreciation0.830.81230.754
Pretty Stable
PB Ratio0.640.66961.1707
Pretty Stable
EV To Sales0.760.79921.94
Very volatile
Inventory Turnover2.782.37972.6722
Slightly volatile
Days Of Inventory On Hand130153154
Slightly volatile
Payables Turnover5.766.34595.9003
Slightly volatile
Research And Ddevelopement To Revenue0.03190.03290.0382
Slightly volatile
Capex To Revenue0.04550.04510.0406
Pretty Stable
Cash Per Share2.361.93532.687
Pretty Stable
Payout Ratio20.0722.5824.649
Slightly volatile
Days Payables Outstanding10957.51791.9629
Pretty Stable
Intangibles To Total Assets0.610.47750.5666
Slightly volatile
Current Ratio1.912.15132.2713
Slightly volatile
Receivables Turnover6.046.75535.9538
Slightly volatile
Shareholders Equity Per Share30.5616.771629.8784
Slightly volatile
Debt To Equity0.280.16590.2308
Pretty Stable
Capex Per Share0.90.6810.8302
Slightly volatile
Revenue Per Share23.5415.112122.3655
Slightly volatile
Interest Debt Per Share2.732.86855.9627
Very volatile
Debt To Assets0.180.12020.1463
Pretty Stable
Graham Number34.4429.730.5582
Slightly volatile
Short Term Coverage Ratios3.864.059810.0773
Very volatile
Operating Cycle190207223
Slightly volatile
Price Book Value Ratio0.640.66961.1707
Pretty Stable
Days Of Payables Outstanding10957.51791.9629
Pretty Stable
Dividend Payout Ratio20.0722.5824.649
Slightly volatile
Company Equity Multiplier1.631.37971.4561
Very volatile
Long Term Debt To Capitalization0.220.12450.2222
Slightly volatile
Total Debt To Capitalization0.210.14230.1727
Pretty Stable
Debt Equity Ratio0.280.16590.2308
Pretty Stable
Quick Ratio1.281.25541.4873
Slightly volatile
Cash Ratio0.470.54360.5255
Slightly volatile
Cash Conversion Cycle111150133
Slightly volatile
Days Of Inventory Outstanding130153154
Slightly volatile
Days Of Sales Outstanding59.554.031769.4393
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.070.5771.2864
Pretty Stable
Price To Book Ratio0.640.66961.1707
Pretty Stable
Fixed Asset Turnover4.924.9734.5825
Pretty Stable
Debt Ratio0.180.12020.1463
Pretty Stable
Price Sales Ratio0.710.74311.7736
Very volatile
Asset Turnover0.550.65310.5226
Slightly volatile
Gross Profit Margin0.390.49770.4722
Slightly volatile
Price Fair Value0.640.66961.1707
Pretty Stable

Avanos Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.4 B1.4 B1.6 B
Pretty Stable
Enterprise Value2.3 B2 B2 B
Pretty Stable

Avanos Fundamental Market Drivers

Avanos Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Avanos Medical Financial Statements

Avanos Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Avanos Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Avanos Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Avanos Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-3.5 M-3.3 M
Total Revenue701.2 M800.1 M
Cost Of Revenue352.2 M445.5 M
Stock Based Compensation To Revenue 0.02  0.01 
Research And Ddevelopement To Revenue 0.03  0.03 
Capex To Revenue 0.05  0.05 
Revenue Per Share 15.11  23.54 
Ebit Per Revenue(0.09)(0.08)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY